Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Articles published by BostonGene

< Previous 1 2 Next >
BostonGene to Present Omnimodal Foundation AI for Cancer and the Immune System at SITC 2025 Annual Meeting
From BostonGene
Via Business Wire
BostonGene to Highlight Omnimodal AI Innovations for Precision Oncology at the 21st Annual Precision Oncology & RadMed Symposium
From BostonGene
Via Business Wire
BostonGene Honored with Five 2025 Stevie® Awards for Technology Excellence
From BostonGene
Via Business Wire
BostonGene Showcases AI-Powered Multimodal Analytics at ESMO Congress 2025 to Advance Cancer Research and Drug Development
From BostonGene
Via Business Wire
BostonGene Named Platinum Winner for AI Research Innovation at 2025 Pinnacle Awards
From BostonGene
Via Business Wire
BostonGene to Participate in the 2025 IASLC World Conference on Lung Cancer
From BostonGene
Via Business Wire
BostonGene Publishes Landmark Study Providing Clinical and Analytical Validation for Its Multimodal RNA and DNA Assay
From BostonGene
Via Business Wire
BostonGene Named “AI-based Drug Discovery Solution of the Year” in 2025 AI Breakthrough Awards Program
From BostonGene
Via Business Wire
BostonGene Announces Collaboration with SWOG Cancer Research Network to Drive Personalized Approaches
From BostonGene
Via Business Wire
BostonGene to Present AI-Powered Solutions Advancing Patient-Centric Drug Development at The Festival of Genomics & Biodata Boston 2025
From BostonGene
Via Business Wire
BostonGene’s Multiomic AI Platform Uncovers Therapeutic Targets in Invasive Lobular Carcinoma, Wins GRASP Advocate Choice Award at ASCO 2025
From BostonGene
Via Business Wire
BostonGene Announces Participation at the American Association for Cancer Research Annual Meeting 2025
From BostonGene
Via Business Wire
BostonGene Appoints Dr. Ferran Prat as Chief Commercial Officer
From BostonGene
Via Business Wire
BostonGene to Participate in the 114th Annual Meeting of the United States and Canadian Academy of Pathology
From BostonGene
Via Business Wire
BostonGene Named a Fierce Life Sciences Innovation Awards Winner in the AI Innovation Category
From BostonGene
Via Business Wire
BostonGene Collaborates with BeiGene to Advance Biomarker Discovery in Mantle Cell Lymphoma
From BostonGene
Via Business Wire
BostonGene Contributes to Friends of Cancer Research White Paper Introducing a Novel Process for Companion Diagnostics for Rare Biomarkers and Indications
From BostonGene
Via Business Wire
BostonGene Evaluates Novel Therapies and Immune System Profiling as a Marker of Response in Patients with Gastrointestinal Cancers
From BostonGene
Via Business Wire
BostonGene Unveils Transformative Breast Cancer Research at 2024 San Antonio Breast Cancer Symposium, Showcasing Precision Tools for Tailored Treatment Approaches
From BostonGene
Via Business Wire
BostonGene Announces Twelve Abstracts Selected for Presentation at the 66th American Society of Hematology Annual Meeting & Exposition
From BostonGene
Via Business Wire
BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2024 Annual Meeting
From BostonGene
Via Business Wire
GlobalData Honors BostonGene with Five Awards in the 2024 Pharmaceutical Technology Excellence Awards
From BostonGene
Via Business Wire
BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s Annual Meeting
From BostonGene
Via Business Wire
BostonGene to Participate in Pathology Visions 2024, Driving Collaborative Advancements in Digital Pathology and Regulatory Science
From BostonGene
Via Business Wire
BostonGene to Showcase Innovative Precision Medicine Strategies for Non-Small Cell Lung Cancer at the Advancing Precision Medicine Conference 2024
From BostonGene
Via Business Wire
Fujita Health University and BostonGene Expand Access to Genomic Cancer Testing with Tumor Portrait™ at Haneda Clinic
From BostonGene
Via Business Wire
BostonGene and Sarah Cannon Research Institute Collaborate to Accelerate the Development of Targeted Cancer Therapies and Improve Patient Outcomes
From BostonGene
Via Business Wire
BostonGene Announces Partnership with Takeda to Evaluate Immunotherapies Using AI-Powered Molecular Profiling
From BostonGene
Via Business Wire
BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Collaborate to Advance Care for Cancer Patients
From BostonGene
Via Business Wire
BostonGene Highlights Its AI-Powered Multiomics Platform at hubXchange’s Immuno-Oncology Xchange Boston 2024
From BostonGene
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.